BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 12193533)

  • 1. Activation of the MAPK pathway enhances sensitivity of MCF-7 breast cancer cells to the mitogenic effect of estradiol.
    Yue W; Wang JP; Conaway M; Masamura S; Li Y; Santen RJ
    Endocrinology; 2002 Sep; 143(9):3221-9. PubMed ID: 12193533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptive hypersensitivity to estradiol: potential mechanism for secondary hormonal responses in breast cancer patients.
    Santen R; Jeng MH; Wang JP; Song R; Masamura S; McPherson R; Santner S; Yue W; Shim WS
    J Steroid Biochem Mol Biol; 2001 Dec; 79(1-5):115-25. PubMed ID: 11850215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of MAP kinase in the enhanced cell proliferation of long term estrogen deprived human breast cancer cells.
    Jeng MH; Yue W; Eischeid A; Wang JP; Santen RJ
    Breast Cancer Res Treat; 2000 Aug; 62(3):167-75. PubMed ID: 11072781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptive mechanisms induced by long-term estrogen deprivation in breast cancer cells.
    Song RX; Santen RJ; Kumar R; Adam L; Jeng MH; Masamura S; Yue W
    Mol Cell Endocrinol; 2002 Jul; 193(1-2):29-42. PubMed ID: 12160999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced estrogen receptor (ER) alpha, ERBB2, and MAPK signal transduction pathways operate during the adaptation of MCF-7 cells to long term estrogen deprivation.
    Martin LA; Farmer I; Johnston SR; Ali S; Marshall C; Dowsett M
    J Biol Chem; 2003 Aug; 278(33):30458-68. PubMed ID: 12775708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive hypersensitivity following long-term estrogen deprivation: involvement of multiple signal pathways.
    Yue W; Wang JP; Conaway MR; Li Y; Santen RJ
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):265-74. PubMed ID: 14623520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular changes associated with the acquisition of oestrogen hypersensitivity in MCF-7 breast cancer cells on long-term oestrogen deprivation.
    Chan CM; Martin LA; Johnston SR; Ali S; Dowsett M
    J Steroid Biochem Mol Biol; 2002 Aug; 81(4-5):333-41. PubMed ID: 12361723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells.
    Jeng MH; Shupnik MA; Bender TP; Westin EH; Bandyopadhyay D; Kumar R; Masamura S; Santen RJ
    Endocrinology; 1998 Oct; 139(10):4164-74. PubMed ID: 9751496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional activation of E2F1 gene expression by 17beta-estradiol in MCF-7 cells is regulated by NF-Y-Sp1/estrogen receptor interactions.
    Wang W; Dong L; Saville B; Safe S
    Mol Endocrinol; 1999 Aug; 13(8):1373-87. PubMed ID: 10446910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
    Tyagi A; Agarwal R; Agarwal C
    Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrasting effects of prenyltransferase inhibitors on estrogen-dependent cell cycle progression and estrogen receptor-mediated transcriptional activity in MCF-7 cells.
    Doisneau-Sixou SF; Cestac P; Chouini S; Carroll JS; Hamilton AD; Sebti SM; Poirot M; Balaguer P; Faye JC; Sutherland RL; Favre G
    Endocrinology; 2003 Mar; 144(3):989-98. PubMed ID: 12586776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
    Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
    Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linkage of rapid estrogen action to MAPK activation by ERalpha-Shc association and Shc pathway activation.
    Song RX; McPherson RA; Adam L; Bao Y; Shupnik M; Kumar R; Santen RJ
    Mol Endocrinol; 2002 Jan; 16(1):116-27. PubMed ID: 11773443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adaptive hypersensitivity to estrogen: mechanism for superiority of aromatase inhibitors over selective estrogen receptor modulators for breast cancer treatment and prevention.
    Santen RJ; Song RX; Zhang Z; Kumar R; Jeng MH; Masamura S; Yue W; Berstein L
    Endocr Relat Cancer; 2003 Jun; 10(2):111-30. PubMed ID: 12790774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
    Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
    Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of long-term estrogen deprivation on apoptotic responses of breast cancer cells to 17beta-estradiol.
    Song RX; Mor G; Naftolin F; McPherson RA; Song J; Zhang Z; Yue W; Wang J; Santen RJ
    J Natl Cancer Inst; 2001 Nov; 93(22):1714-23. PubMed ID: 11717332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estradiol hypersensitivity and mitogen-activated protein kinase expression in long-term estrogen deprived human breast cancer cells in vivo.
    Shim WS; Conaway M; Masamura S; Yue W; Wang JP; Kmar R; Santen RJ
    Endocrinology; 2000 Jan; 141(1):396-405. PubMed ID: 10614662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oestrogen receptor-mediated modulation of the EGFR/MAPK pathway in tamoxifen-resistant MCF-7 cells.
    Hutcheson IR; Knowlden JM; Madden TA; Barrow D; Gee JM; Wakeling AE; Nicholson RI
    Breast Cancer Res Treat; 2003 Sep; 81(1):81-93. PubMed ID: 14531500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell context-dependent differences in the induction of E2F-1 gene expression by 17 beta-estradiol in MCF-7 and ZR-75 cells.
    Ngwenya S; Safe S
    Endocrinology; 2003 May; 144(5):1675-85. PubMed ID: 12697671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of mitogen-activated protein kinase and phosphatidylinositol 3-kinase activity in MCF-7 cells prevents estrogen-induced mitogenesis.
    Lobenhofer EK; Huper G; Iglehart JD; Marks JR
    Cell Growth Differ; 2000 Feb; 11(2):99-110. PubMed ID: 10714766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.